Salicylate Measurement: Clinical Usefulness and Methodology

References

• Goldfrank L. R., Bresnitz E. A., Salicylates. Toxicologic Emergencies. Allpeton-Century-Crofts, New York 1982; 59
   Google Scholar
• Buchanan W. W., Rooney P. J., Rennie J. A. Aspirin and the salicylates. Clin. Rheum. Dis. 1979; 5: 499
   Google Scholar
• Pinals R. S. Approaches to rheumatoid arthritis and osteoarthritis: an overview. Am. J. Med. 1983; 75(Suppl. 4B)2
   PubMed Web of Science ®Google Scholar
• Levy G. Clinical pharmacokinetic of salicylate: a re-assessment. Br. J. Clin. Pharmacol. 1980; 10: 285S
   PubMed Web of Science ®Google Scholar
• Needs C. J., Brooks P. M. Clinical pharmacokinetics of the salicylate. Clin. Pharmacokinet. 1985; 10: 164
   PubMed Web of Science ®Google Scholar
• Vane J. R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature (London) 1971; 231: 232
   Web of Science ®Google Scholar
• Marcus A. J. Aspirin as an antithrombotic medication. N. Engl. J. Med. 1983; 309: 1515
   PubMed Web of Science ®Google Scholar
• Rowland M., Riegelman S., Harris P. A., Sholkoff S. D. Absorption kinetics of aspirin in man following oral administration of an aqueous solution. J. Pharm. Sci. 1972; 61: 379
   PubMed Web of Science ®Google Scholar
• Martin B. K. The formulation of aspirin. Advances in Pharmaceutical Sciences, Bean, et al. Academic Press, New York 1971; Vol. 3: 107
   Google Scholar
• Liberman S. V., Wood J. H. Aspirin formulation and absorption rate. II. Influence on serum levels of tablets, antacids and solutions. J. Pharm. Sci. 1986; 53: 1492
   Google Scholar
• Briggs D. F., Coutts R. T., Walter L. J. A note of the bioavailability of five Canadian brands of acetylsalicylic acid tablets. Can. J. Pharmacol. Sci. 1977; 12: 23
   Web of Science ®Google Scholar
• Rose-Lee L. M., Elms M. J., Cham B. E., Bochner F., Bunce I. H., Edie M. J. Plasma levels of aspirin following effervescent and enteric coated tablets, and their effect on platelet function. Eur. J. Clin. Pharmacol. 1982; 23: 545
   PubMed Web of Science ®Google Scholar
• Orozco-Alcala J. J., Baum J. Regular and enteric coated aspirin: a re-evaluation. Arthritis Rheum. 1979; 22: 1034
   PubMed Web of Science ®Google Scholar
• Reynolds R. C., Cuff L. Interaction of serum and sodium salicylate: changes during acute infection and its influence on pharmacological activity. Johns Hopkins Hosp. Bull. 1960; 107: 278
   PubMedGoogle Scholar
• Borga O., Odar-Cederlof I., Rinberger V., Norlin A. Protein binding of salicylate in uremic and normal plasma. Clin. Pharmacol. Ther. 1976; 20: 464
   PubMed Web of Science ®Google Scholar
• Wosilait W. D. Theoretical analysis of the binding of salicylate by human serum albumin: the relationship between free and bound drug and therapeutic levels. Eur. J. Clin. Pharmacol. 1976; 9: 285
   PubMed Web of Science ®Google Scholar
• Furst D. E., Tozer T. N., Melmon K. L. Salicylate clearance, the resultant of protein binding and metabolism. Clin. Pharmacol. Ther. 1979; 26: 381
   Web of Science ®Google Scholar
• Graham G. G., Champion G. D., Day R. O., Paul P. D. Patterns of plasma concentrations and urinary excretion of salicylate in rheumatoid arthritis. Clin. Pharmacol. Ther. 1977; 22: 410
   PubMed Web of Science ®Google Scholar
• Wilson J. T., Brown R. D., Bocchini J. A., Kearns G. L. Efficacy, disposition and pharmacodynamics of aspirin, acetaminophen and choline salicylate in young febrile children. Ther. Drug Monit. 1982; 4: 147
   PubMed Web of Science ®Google Scholar
• Rubin G. M., Tozer T. N., Oie S. Concentration-dependence of salicylate distribution. J. Pharm. Pharmacol. 1983; 35: 115
   PubMed Web of Science ®Google Scholar
• Soren A. Kinetics of salicylates in blood and joint fluid. Eur. J. Clin. Pharmacol. 1979; 16: 279
   Web of Science ®Google Scholar
• Wanwimolruk S., Birkett D. J., Brooks P. M. Binding of non-steroidal anti-inflammatory drugs in plasma and synovial fluid of arthritis patients. Br. J. Clin. Pharmacol. 1983; 15: 91
   PubMed Web of Science ®Google Scholar
• Hill J. B. Experimental salicylate poisoning: observation of the effects of altering blood pH on tissue and plasma salicylate concentrations. Pediatrics 1971; 47: 658
   PubMed Web of Science ®Google Scholar
• Roberts M. S., Rumble R. H., Brooks P. M. Salivary salicylate secretion and flow rate. Br. J. Clin. Pharmacol. 1978; 6429
   Web of Science ®Google Scholar
• Levy G., Proknall J. A., Oluf R., Pachman L. M. Relationship between saliva salicylate concentration and free or total salicylate concentration in serum of children with juvenile rheumatoid arthritis. Clin. Pharmacol. Ther. 1980; 27: 619
   PubMed Web of Science ®Google Scholar
• Levy G. Pharmacokinetics of salicylate in man. Drug Metab. Rev. 1979; 9: 3
   PubMed Web of Science ®Google Scholar
• Costello P. B., Caruana J. A., Green F. A. The relative roles of hydrolases of the erythrocyte and other tissues in controlling aspirin survival in vitro. Arthritis Rheum. 1984; 27: 422
   PubMedGoogle Scholar
• Windorfer A., Kuenzer W., Urbanck R. The influence of age on the activity of acetylsalicylic acid esterase and protein binding. Eur. J. Clin. Pharmacol. 1974; 7: 227
   PubMed Web of Science ®Google Scholar
• Gupta J. P., Gupta V. Serum aspirin esterase activity in women with habitual aspirin ingestion. Clin. Chim. Acta 1977; 81: 261
   PubMed Web of Science ®Google Scholar
• Menguy R., Desbaillets L., Masters Y. F., Okabe S. Evidence for sex linked differences in aspirin metabolism. Nature (London) 1972; 239: 102
   PubMed Web of Science ®Google Scholar
• Rainsford K. D., Schweitzer A., Brune K. Distribution of acetyl compared to salicyl moiety of acetylsalicylic acid. Biochem. Pharmacol. 1983; 32: 1307
   Web of Science ®Google Scholar
• Levy G. Pharmacokinetics of salicylate elimination in man. J. Pharm. Sci. 1965; 54: 959
   PubMed Web of Science ®Google Scholar
• Paulus H. E., Siegel M., Mongan E., et al. Variations of serum concentrations and half-life of salicylate in patients with rheumatoid arthritis. Arthritis Rheum. 1971; 14: 527
   PubMed Web of Science ®Google Scholar
• Muller F., Hundt H. K. L., Muller D. G. Pharmacokinetic and pharmacodynamic implications of long-term administration of non-steroidal anti-inflammatory agents. Int. J. Clin. Pharmacol. 1977; 15: 397
   Google Scholar
• Rumble R. H., Brooks P. M., Roberts M. S. Metabolism of salicylate during chronic aspirin therapy. Br. J. Clin. Pharmacol. 1977; 15: 397
   Google Scholar
• Olsson B. Decreasing serum salicylate concentrations during long-term administration of acetylsalicylic acid in healthy volunteers. Scan. J. Rheum. 1983; 12: 81
   PubMed Web of Science ®Google Scholar
• Furst D. E., Gupta N., Paulus H. E. Salicylate metabolism in twins. Evidence suggesting a genetic influence and induction of salicylate formation. J. Clin. Invest. 1977; 60: 32
   PubMed Web of Science ®Google Scholar
• Flower R. J., Moncada S., Vane J. R. Analgesic-antipyretic and anti-inflammatory agents: drugs employed in the treatment of gout, chap. 1. The Pharmacological Basis of Therapeutics7th ed., A. G. Gilman, L. S. Goodman, T. W. Rall, F. Murad. Macmillan, New York 1985; 674
   Google Scholar
• Brune K. Y. Prostaglandins and the mode of action of antipyretic analgesic drugs. Am. J. Med. 1983; 75(Suppl. 5A)19
   PubMed Web of Science ®Google Scholar
• Hamburg M., Svensson J. Prostaglandin endoperoxides: novel transformation of arachidonic acid in human platelets. Proc. Natl. Acad. Sci. U.S.A. 1974; 71: 3400
   PubMed Web of Science ®Google Scholar
• Roth G. R., Siok C. J. Acetylation of the NH2-terminal serine of prostaglandin synthetase by aspirin. J. Biol. Chem. 1978; 253: 3782
   PubMed Web of Science ®Google Scholar
• Moncada S. R., Vane J. R. Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin. Pharmacol. Rev. 1978; 30: 293
   PubMed Web of Science ®Google Scholar
• May G. S., Eberlein K. A., Furbery C. D., Passamain E. R., DeMets D. S. Secondary prevention after myocardial infarction: a review of long-term trials. Prog. Cardiovasc. Dis. 1982; 24: 331
   PubMed Web of Science ®Google Scholar
• Kistler J. P., Ropper A. H., Heros R. C. Medical progress: therapy of ischemic cerebral vascular disease due to atherothrombosis. N. Engl. J. Med. 1984; 311: 27, 100
   Google Scholar
• Moncada S., Vane J. R. Arachidonic acid metabolites and the interactions between platelets and blood-vessel wall. N. Engl. J. Med. 1979; 300: 1142
   PubMed Web of Science ®Google Scholar
• Marcus A. J. Aspirin and thromboembolism: a possible dilemma. N. Engl. J. Med. 1977; 297: 1284
   PubMed Web of Science ®Google Scholar
• Bunting S., Grygleewski R., Moncada S., Vane J. R. Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac arteries and inhibits platelet aggregation. Prostaglandins 1976; 12: 897
   PubMed Web of Science ®Google Scholar
• Hamburg M., Svensson J., Sammellson B. Troboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc. Natl. Acad. Sci. U.S.A. 1975; 72: 2994
   PubMed Web of Science ®Google Scholar
• Patrignani P., Filabozzi P., Patrono C. Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects. J. Clin. Invest. 1982; 69: 1366
   PubMed Web of Science ®Google Scholar
• Weksler B. B., Pett S. B., Alonso D., et al. Differential inhibition by aspirin of vascular and platelet prostaglandin synthesis in atherosclerotic patients. N. Engl. J. Med. 1983; 308: 800
   PubMed Web of Science ®Google Scholar
• Pederson A. K., Fitzgerald G. A. Dose relate, kinetics of aspirin. Presystemic acetylation of platelet cyclo oxygenase. N. Engl. J. Med. 1984; 311: 1206
   PubMed Web of Science ®Google Scholar
• de Gaetano G., Cerletti C., Dejana E., Latini R. Pharmacology of platelet inhibition in humans: implications of the salicylate-aspirin interaction. Circulation 1985; 72: 1185
   PubMed Web of Science ®Google Scholar
• Zucker M. B., Rothwell K. G. Differential influences of salicylate compounds on platelets aggregation and serotonin release. Curr. Ther. Res. 1978; 23: 194
   Web of Science ®Google Scholar
• Vargaftig B. B. The inhibition of cyclo-oxygenase of rabbit platelet by aspirin is prevented by salicylic acid and by phenanthrolines. Eur. J. Pharmacol 1978; 50: 231
   PubMed Web of Science ®Google Scholar
• Hamburg M. Inhibition of prostaglandin synthesis in man. Biochem. Biophys. Res. Commun. 1972; 49: 720
   PubMed Web of Science ®Google Scholar
• Seed J. C. A clinical comparison of the antipyretic potency of aspirin and sodium salicylate. Clin. Pharmacol. Ther. 1965; 6: 354
   PubMed Web of Science ®Google Scholar
• Blechman W. J., Lechner B. L. Clinical comparative evaluation of choline magnesium trisalicylate and acetylsalicylic acid in rheumatoid arthritis. Rheumatol. Rehabil. 1979; 18: 119
   PubMedGoogle Scholar
• Vargaftig B. B. Salicyclic acid fails to inhibit generation of thromboxane A2 activity in platelets after in vivo administration to the rat. J. Pharm. Pharmacol. 1978; 30: 101
   PubMed Web of Science ®Google Scholar
• Ali M., McDonald J. W. D. Interference by sulfinpyrazone and salicylate of aspirin inhibition of platelet cyclo-oxygenase activity. Prostaglandins Leukotienes Med. 1979; 3: 327
   Google Scholar
• Merino J., Livio M., Rajtar G., de Gaetano G. Salicylate reverses in vitro aspirin inhibition of rat platelet and vascular prostaglandin generation. Biochem. Pharmacol. 1980; 29: 1093
   PubMed Web of Science ®Google Scholar
• Dejana E., Cerletti C., de Castellarnau C., Livio M., Galletti F., Latini R., de Gaetano G. Salicylate-aspirin interaction in the rat. Evidence that salicylate accumulating during aspirin administration may protect vascular prostacyclin from aspirin induced inhibition. J. Clin. Invest. 1981; 68: 1108
   PubMed Web of Science ®Google Scholar
• Cerletti C., Bonati M., del Maschio A., Galletti F., Dejana E., Tongnoni G., de Gaetano G. Plasma levels of salicylate and aspirin in healthy volunteers: relevance to drug interaction on platelet function. J. Lab. Clin. Med. 1984; 103: 869
   PubMed Web of Science ®Google Scholar
• Peterson D. A., Gerrard J. M., Rao G. H. R., White J. G. Salicylic acid inhibition of the irreversible effect of acetysalicylic acid on prostaglandin synthetase may be due to composition for the enzyme cationic binding site. Prostaglandins Med. 1981; 6: 161
   PubMedGoogle Scholar
• Hollister L. E. Measuring measurin: problems of oral prolonged-action medications. Clin. Pharmacol. Ther. 1972; 13: 1
   PubMed Web of Science ®Google Scholar
• Clark A., Walton W. W. Effect of safety packaging on aspirin ingestion by children. Pediatrics 1979; 63: 687
   PubMed Web of Science ®Google Scholar
• Done A. K. Aspirin overdosage: incidence, diagnosis and management. Pediatrics 1978, Suppl. 62: 890
   PubMedGoogle Scholar
• Howrie D. L., Moriarty R., Breit R. Candy flavoring as a source of salicylate poisoning. Pediatrics 1985; 75: 869
   PubMed Web of Science ®Google Scholar
• Proudfoot A. T. Toxicity of salicylates. Am. J. Med. 1983; 75(Suppl. 5A)99
   PubMed Web of Science ®Google Scholar
• Greer H. D., Ward H. P., Corbin K. Chronic salicylate intoxication in adults. JAMA 1965; 193: 555
   PubMed Web of Science ®Google Scholar
• Anderson R. J., Potts D. E., Gabow P. A., Rumack B. H., Schrier R. W. Unrecognized adult salicylate intoxication. Ann. Intern Med. 1976; 85: 745
   PubMed Web of Science ®Google Scholar
• Mitchell I. Therapeutic salicylate poisoning in children. Br. Med. J. 1979; 1: 1081
   PubMed Web of Science ®Google Scholar
• Snodgrass M. W., Rumack B. H. Salicylate toxicity following therapeutic doses in young children. Clin. Toxicol. 1981; 18: 247
   PubMed Web of Science ®Google Scholar
• McLntire M. S., Angle C. R. Aspirin fatalities—the new taxonomy. Pediatrics 1982; 69: 249
   PubMed Web of Science ®Google Scholar
• Gaudreault P., Temple A. R., Lovejoy F. H. The relative severity of acute versus chronic salicylate poisoning in children: a clinical comparison. Pediatrics 1982; 70: 566
   PubMed Web of Science ®Google Scholar
• Clark J. H., Wilson W. G. A 16-day-old breast-fed infant with metabolic acidosis caused by salicylate. Clin. Pediatr. 1981; 20: 53
   PubMed Web of Science ®Google Scholar
• Paytner A. S., Alexander F. W. Salicylate intoxication caused by teething ointment. Lancet 1979; 2: 1132
   Web of Science ®Google Scholar
• Davis M. G., Vella Briffa D., Greaves M. W. Systemic toxicity from topically applied salicylic acid. Br. Med. J. 1979; 1: 661
   Google Scholar
• Temple A. R. Acute and chronic effects of aspirin toxicity and their treatment. Arch. Intern. Med. 1981; 14: 364
   Google Scholar
• Winters R. W., White J. S., Hughes M. C., Ordway M. C. Disturbance of acid base equilibrium in salicylate intoxication. Pediatrics 1959; 23: 260
   PubMed Web of Science ®Google Scholar
• Proudfoot A. T., Brown S. S. Acidemia and salicylate poisoning in adults. Br. Med. J. 1969; 2: 547
   PubMedGoogle Scholar
• Gabow P. A., Potts D. E., Scrier R. W., Anderson R. J. The acid-base abnormalities of salicylate intoxication. Clin. Res. 1976; 24(Suppl. 126A)
   Google Scholar
• Brenner B. E., Simon R. R. Management of salicylate intoxication. Drugs 1982; 24: 335
   PubMed Web of Science ®Google Scholar
• Vivian A. S., Goldberg I. B. Recognizing chronic salicylate intoxication in the elderly. Geriatrics 1982; 37: 91
   PubMed Web of Science ®Google Scholar
• Done A. K. Salicylate intoxication—significance of measurement of salicylate in blood in cases of acute ingestion. Pediatrics 1960; 26: 800
   PubMed Web of Science ®Google Scholar
• Ferguson R. K., Boutros A. R. Death following self-poisoning with aspirin. JAMA 1970; 213: 1186
   PubMed Web of Science ®Google Scholar
• Kaufman F. L., Dubansky A. S. Darvon poisoning with delayed salicylism: a case report. Pediatrics 1972; 49: 610
   PubMed Web of Science ®Google Scholar
• Todd P. J., Sills J. A., Harris F., Cowen J. M. Problems with overdoses of sustained-release aspirin. Lancet 1981; 1: 777
   PubMed Web of Science ®Google Scholar
• Kwong T. C., Laczin J., Baum J. Self-poisoning with enteric-coated aspirin. Am. J. Clin. Pathol. 1983; 80: 888
   PubMed Web of Science ®Google Scholar
• Kaye S. Handbook of Emergency Toxicology4th ed. Charles C Thomas, Springfield, III. 1980; 152
   Google Scholar
• Trinder P. Rapid determination of salicylate in biological materials. Biochem. J. 1954; 57: 301
   PubMed Web of Science ®Google Scholar
• Queen C. A., Frings C. S. Effect of sodium azide on Trinder's method for the determination of salicylate. Clin. Chim. Acta 1973; 45: 307
   PubMed Web of Science ®Google Scholar
• Johnson P. K., Free H. M., Free A. H. A simplified urine screening test for salicylate intoxication. J. Pediatr. 1963; 63: 949
   PubMed Web of Science ®Google Scholar
• Smyth C. J., Bravo J. F. Antirheumatic drugs: clinical pharmacological and therapeutic aspects. Drugs 1975; 10: 394
   PubMed Web of Science ®Google Scholar
• Vesell E. R. Relationship between drug distribution and therapeutic effects in man. Annu. Rev. Pharmacol. 1974; 14: 249
   Google Scholar
• Levy G., Giacomini K. M. Rational aspirin dosage regimens. Clin. Pharmacol. Ther. 1978; 23: 247
   PubMed Web of Science ®Google Scholar
• Mandelli M., Tognoni G. Monitoring plasma concentrations of salicylate. Clin. Pharmacokinet. 1980; 5: 424
   PubMed Web of Science ®Google Scholar
• Doughty R. A., Giesecke L., Athreya B. Salicylate therapy in juvenile rheumatoid arthritis. Am. J. Dis. Child. 1980; 134: 461
   PubMedGoogle Scholar
• Baum J. Aspirin in the treatment of juvenile arthritis. Am. J. Med. 1983; 74(Suppl. 6A)10
   PubMed Web of Science ®Google Scholar
• Makela A-L., Yrjana T., Mattila M. Dosage of salicylates for children with juvenile rheumatoid arthritis. Acta Paediatr. Scand. 1979; 68: 423
   PubMed Web of Science ®Google Scholar
• Baredare M., Cislaghi G. U., Mandelli M., Sereni F. Value of monitoring plasma salicylate levels in treating juvenile rheumatoid arthritis. Arch. Dis. Child. 1978; 53: 381
   PubMed Web of Science ®Google Scholar
• Cuny G., Royer R. J., Mur J. M., Serot J. M., Faure G., Netter P., Maillard A., Penin F. Pharmacokinetics of salicylates in elderly. Gerontology 1979; 25: 49
   PubMed Web of Science ®Google Scholar
• Roberts M. S., Rumble R. H., Wanwinolruk S., Thomas D., Brooks P. M. Pharmacokinetics of aspirin and salicylate in elderly subjects and in patients with alcoholic liver disease. Eur. J. Clin. Pharmacol. 1983; 25: 253
   PubMed Web of Science ®Google Scholar
• Hansten P. D., Hayton W. L. Effect of antacid and ascorbic acid on serum salicylate concentration. J. Clin. Pharmacol. 1980; 7: 326
   Google Scholar
• Klinenberg J. R., Miller F. Effect of corticosteroids on blood salicylate concentration. JAMA 1965; 194: 601
   PubMed Web of Science ®Google Scholar
• Mongan E., Kelly P., Nies K., Porter W. W., Paulus H. E. Tinnitus as an indication of therapeutic serum salicylate levels. JAMA 1973; 226: 142
   PubMed Web of Science ®Google Scholar
• Litt I. F., Cuskey W. R. Compliance with salicylate therapy in adolescents with juvenile rheumatoid arthritis. Am. J. Dis. Child. 1981; 135: 434
   PubMedGoogle Scholar
• Kwong T. C. Free drug measurements: methodology and clincial significance. Clin. Chim. Acta 1985; 151: 193
   PubMed Web of Science ®Google Scholar
• Ekstrand R., Alvan G., Borga O. Concentration dependent plasma protein binding of salicylate in rheumatoid patients. Clin. Pharmacokinet. 1979; 4: 137
   PubMed Web of Science ®Google Scholar
• Alvan G., Bergman U., Gustafsson L. High unbound fraction of salicylate in plasma during intoxication. Br. J. Clin. Pharmacol. 1981; 11: 625
   PubMed Web of Science ®Google Scholar
• Lowenthal D. T., Briggs W. A., Levy G. Kinetics of salicylate elimination by anephric patients. J. Clin. Invest. 1974; 54: 1221
   PubMed Web of Science ®Google Scholar
• Lesko L. J., Narang P. K., Yeager L., Culter N. R. Salicylate protein binding in serum from young and elderly subjects as measured by diafiltration. Eur. J. Clin. Pharmacol. 1985; 28: 339
   PubMed Web of Science ®Google Scholar
• Perucca E., Crema A. Plasma protein binding of drugs in pregnancy. Clin. Pharmacokinet. 1982; 7: 336
   PubMed Web of Science ®Google Scholar
• Dean M., Stock B., Patterson R. J., Levy G. Serum protein binding of drugs during and after pregnancy in humans. Clin. Pharmacol. Ther. 1980; 28: 1253
   Web of Science ®Google Scholar
• Lovecchio J. L., Krasner J., Yaffe S. J. Serum protein binding of salicylate during pregnancy and the puerperium. Dev. Pharmacol. Ther. 1981; 2: 172
   PubMedGoogle Scholar
• Krasner J., Giacoia F. P., Yaffe S. J. Drug binding in the newborn infant. Ann. N.Y. Acad. Sci. 1973; 226: 101
   PubMed Web of Science ®Google Scholar
• Greenblatt D. J., Sellers E. M., Koch-Weseer J. Importance of protein binding for the interpretation of serum or plasma drug concentrations. J. Clin. Pharmacol. 1982; 22: 259
   PubMed Web of Science ®Google Scholar
• Bowers W. F., Fulton S., Thompson J. Ultrafiltration vs. equilibrium dialysis for determination of free fraction. Clin. Pharmacokinet. 1984; 9(Suppl. 1)49
   PubMedGoogle Scholar
• Ritschel W. A., Thrompson G. A. Monitoring of drug concentrations in saliva: a non-invasive pharmacokinetic procedure. Methods Find. Exp. Clin. Pharmacol. 1983; 5: 511
   PubMed Web of Science ®Google Scholar
• Mucklow J. C. The use of saliva in therapeutic drug monitoring. Ther. Drug Monk. 1982; 4: 229
   Web of Science ®Google Scholar
• Natelson S. Microtechniques of Clinical Chemistry for the Routine Laboratory. Charles C Thomas, Springfield, Ill. 1957; 332
   Google Scholar
• MacDonald R. P. Salicylate. Stand. Methods Clin. Chem. 1965; 5: 237
   Google Scholar
• Badcock N. R., Penna A. C., Everett D. S., Sansom. Aspirin metabolites causing misinterpretation of paracetamol results. Ann. Clin. Biochem. 1984; 21: 527
   PubMed Web of Science ®Google Scholar
• Kang E. S., Todd T. A., Capaci M. T., Schwenzer K., Jabbour J. T. Measurement of true salicylate concentrations in serum from patients with Reye's syndrome. Clin. Chem. 1983; 29: 1012
   PubMed Web of Science ®Google Scholar
• Andersen B. D., Alexander M. S., Ng K. J., Bianchine J. R. Aspirin and Reye's disease: a reinterpretation. Lancet 1982; 1: 903
   Web of Science ®Google Scholar
• Hurwitz E. S., Barrett M. J., Bregman D., et al. Public health service study on Reye's syndrome and medications. N. Engl. J. Med. 1985; 313: 14, 849
   PubMed Web of Science ®Google Scholar
• Partin J. S., Partin J. C., Schubert W. K., Hammond J. G. Serum salicylate concentration in Reye's disease. Lancet 1982; 1: 191
   PubMed Web of Science ®Google Scholar
• Mutchie K. D., Saunders G. H., Hanissian A. S., Powe T. E. Interlaboratory salicylate variability. J. Rheum. 1980; 7: 737
   PubMed Web of Science ®Google Scholar
• Kwong T., Adams N., Young N. Rapid determination of salicylate in serum on a centrifugal analyzer. Clin. Biochem. 1984; 17: 3, 170
   Web of Science ®Google Scholar
• Schacter D., Manis J. G. Salicylate and salicyl conjugates: fluorimetric estimation, biosynthesis and renal excretion in man. J. Clin. Invest. 1958; 37: 800
   PubMed Web of Science ®Google Scholar
• Rowland M., Riegelman S. Determination of acetylsalicylic acid and salicylic acid in plasma. J. Pharm. Sci. 1967; 56: 717
   PubMed Web of Science ®Google Scholar
• Jacobs C. J., Pesce M. Micromeasurement of plasma salicylate in arthritis children. Arthritis Rheum. 1978; 21: 129
   PubMedGoogle Scholar
• You K., Bittikofer J. A. Quantification of salicylate in serum by use of salicylate hydroxylase. Clin. Chem. 1984; 30: 1549
   PubMed Web of Science ®Google Scholar
• Longenecker R. W., Trafton J. E., Edwards R. B. A tableted enzymic reagent for salicylate, for use in a discrete multiwavelength analytical system (PARAMAX). Clin. Chem. 1984; 30: 1369
   PubMed Web of Science ®Google Scholar
• Hammond P. M., Scawen M. D., Atkinson T., Price C. P., Campbell R. S. Enzyme-based salicylate estimation. Lancet 1985; 2: 508
   PubMed Web of Science ®Google Scholar
• You K. Polarographic quantification of salicylate in serum by salicylate hydroxylase. Clin. Chim. Acta 1985; 149: 281
   PubMed Web of Science ®Google Scholar
• Chubb S. A. P., Campbell R. S., Ramsay J. R., Hammond P. M., Atkinson T., Price C. P. An enzyme mediated, colorimetric method for the measurement of salicylate. Clin. Chim. Acta 1986; 155: 209
   PubMed Web of Science ®Google Scholar
• Davidson C., Zimmerman E. G., Smith P. V. On the metabolism of methyl salicylate. J. Pharmacol. Exp. Ther. 1960; 132: 207
   Web of Science ®Google Scholar
• Tam Y. K., Au D. S. L., Abbott F. S. Improved gas-liquid chromatographic-flame ionization detection assay of acetylsalicylic and salicylic acids. J. Chromatogr. 1979; 174: 239
   PubMed Web of Science ®Google Scholar
• Walter L. J., Biggs D. F., Couts R. T. Simultaneous GLC estimation of salicylic acid and aspirin in plasma. J. Pharm. Sci. 1974; 63: 1754
   PubMed Web of Science ®Google Scholar
• Brandon R. A., Eadie M. J., Smith M. T. A sensitive liquid chromatographic assay for plasma aspirin and salicylate concentrations after low doses of aspirin. Ther. Drug Monit. 1985; 7: 216
   PubMed Web of Science ®Google Scholar
• Dadgar D., Climax J., Lambe R., Darragh A. High-performance liquid chromatographic determination of certain salicylates and their major metabolites in plasma following topical administration of a liniment to healthy subjects. J. Chromatogr. 1985; 342: 315
   PubMed Web of Science ®Google Scholar
• Tebbett I. R., Omile C. I. Determination of paracentamol, salicylic acid and acetylsalicylic acid in serum by high-performance liquid chromatography. J. Chromatogr. 1985; 329: 196
   PubMed Web of Science ®Google Scholar
• Levine B., Caplan Y. H. Liquid chromatographic determination of salicylate and methyl salicylate in blood and application to a postmortem case. J. Anal. Toxicol. 1984; 8: 239
   PubMed Web of Science ®Google Scholar
• Mays D. C., Sharp D. E., Beach C. A., Kershaw R. A., Bianchine J. R., Gerber N. Improved method for the determination of aspirin and its metabolites in biological fluids by high-performance liquid chromatography: applications to human and animal studies. J. Chromatogr. 1984; 311: 301
   PubMed Web of Science ®Google Scholar
• O'Kruk R. J., Adams M. A., Philip R. B. Rapid and sensitive determination of acetylsalicylic acid and its metabolites using reversed-phase high-performance liquid chromatography. J. Chromatogr. 1984; 310: 343
   PubMed Web of Science ®Google Scholar
• Bakar S. K., Niazi S. High-performance liquid chromatographic determination of aspirin and its metabolites in plasma and urine. J. Pharm. Sci. 1983; 72: 1020
   PubMed Web of Science ®Google Scholar
• Reidl U. Determination of acetylsalicylic acid and metabolites in biological fluids by high-performance liquid chromatography. J. Chromatogr. 1983; 272: 325
   PubMed Web of Science ®Google Scholar
• Buskin J. N., Upton R. A., Williams R. L. Improved liquid-chromatography of aspirin, salicylate, and salicyluric acid in plasma, with a modification for determining aspirin metabolites in urine. Clin. Chem. 1982; 28: 1200
   PubMed Web of Science ®Google Scholar
• Rumble R. H., Roberts M. S., Wanwimolruk S. Determination of aspirin and its major metabolites in plasma by high-performance liquid chromatography without solvent extraction. J. Chromatogr. 1981; 225: 252
   PubMed Web of Science ®Google Scholar
• Taguchi V. Y., Cotton M. L., Yates C. H., Millar J. F. Determination of drug stability in aspirin tablet formulations by high-pressure liquid chromatography. J. Pharm. Sci. 1981; 70: 64
   PubMed Web of Science ®Google Scholar
• Harrison L. I., Funk M. L., Ober R. E. High-pressure liquid chromatographic determination of salicylsalicylic acid, aspirin, and salicylic acid in human plasma and urine. J. Pharm. Sci. 1980; 69: 1268
   PubMed Web of Science ®Google Scholar
• Lo L. Y., Bye A. Specific and sensitive method for the determination of aspirin and salicylic acid in plasma using reversed-phase high-pressure liquid chromatography. J. Chromatogr. 1980; 181: 473
   PubMed Web of Science ®Google Scholar
• Cham B. E., Ross-Lee L., Bochner F., Imhoff D. M. Measurement and pharmacokinetics of acetylsalicylic acid by novel high performance liquid chromatographic assay. Ther. Drug Monit. 1980; 2: 365
   PubMed Web of Science ®Google Scholar
• Lubran M. M., Steen S. N., Smith R. L. Measurement of salicylsalicylic acid and salicylic acid in plasma by high pressure liquid chromatography. Ann. Clin. Lab. Sci. 1979; 9: 501
   PubMed Web of Science ®Google Scholar
• Cham B. E., Johns D., Bochner F., Imhoff D. M., Rowland M. Simultaneous liquid-chromatographic quantitation of salicylic acid, salicyluric acid, and gentisic acid in plasma. Clin. Chem. 1979; 25: 1420
   PubMed Web of Science ®Google Scholar
• Peng G. W., Gadalla M. A. F., Smith V., Peng A., Chioti W. L. Simple and rapid high-pressure liquid chromatographic simultaneous determination of aspirin, salicylic acid, and salicyluric acid in plasma. J. Pharm. Sci. 1978; 67: 710
   PubMed Web of Science ®Google Scholar
• Blair D., Rumack B. H., Peterson R. G. Analysis for salicylic acid in serum by high-performance liquid chromatography. Clin. Chem. 1978; 24: 1543
   PubMed Web of Science ®Google Scholar
• Terweij-Groen C. P., Vahlkamp T., Kraak J. C. Rapid, direct determination of trace amounts of salicylic acid in deproteinized serum by means of high-pressure liquid-liquid chromatography. J. Chromatogr. 1978; 145: 115
   PubMed Web of Science ®Google Scholar
• Ali S. L. Application of gas-liquid chromatography and high-performance liquid chromatography to the analysis of trace amounts of salicylic acid, acetylsalicylic anhydride and acetylsalicylsalicylic acid in aspirin samples and aspirin formulations. J. Chromatogr. 1976; 126: 651
   PubMed Web of Science ®Google Scholar
• Kwong T. C. Analysis of acetylsalicylic acid and its metabolites by liquid chromatography. J. Liquid Chromatogr.
   Google Scholar
• Aspirin: what dose?. Lancet 1986; 1: 592
   PubMed Web of Science ®Google Scholar
• Kurz H., Trunk H., Weitz B. Evaluation of methods to determine protein binding of drugs. Arzneim. Forsch. 1977; 27: 1373
   PubMed Web of Science ®Google Scholar
• Behm H. L., Wagner J. G. Errors in interpretation of data from equilibrium dialysis protein binding experiments. Res. Commun. Chem. Pathol. Pharmacol. 1979; 26: 1, 46
   Google Scholar
• Smith J. B., Jubiz W. A source of error in equilibrium dialysis. Steroids 1980; 36: 393
   PubMed Web of Science ®Google Scholar
• Gupta S. K., Stoltzfus R., de Castro A. F. Salicylate hydrolase free of NADH oxidase activity from pseudomonas. Clin. Chem. 1986; 32: 1061
   Web of Science ®Google Scholar
• Kwong T. C., unpublished results
   Google Scholar